Back

Disrupted myelin homeostasis in grey matter of Alzheimer's disease

Tiane, A.; Willems, E.; Koole, L.; Schepers, M.; van den Hove, D.; Vanmierlo, T.

2026-07-08 neuroscience
10.64898/2026.07.08.737146 bioRxiv
Show abstract

Alzheimer's disease (AD) is characterized not only by amyloid-beta; plaques, tau neurofibrillary tangles and associated neuronal loss, but also by alterations in non-neuronal cell types essential for neuronal support. Oligodendrocytes and their myelin sheaths play a central role in maintaining axonal function, yet detailed molecular profiling of myelin dynamics in the human AD brain remains limited. Although neuroimaging studies increasingly highlight myelin degeneration in white matter as an important contributor to AD pathophysiology, the status of myelin within cortical grey matter is less well understood. Here, we performed a detailed histopathological characterization of myelin integrity and oligodendrocyte dynamics in both grey and white matter of the middle temporal gyrus (MTG), making use of post-mortem tissue from AD cases (n = 15) and age-, sex-, and APOE genotype-matched controls (n = 15). Strikingly, we identified a specific vulnerability of cortical grey matter myelin in AD, whereas white matter myelin appeared relatively preserved. This selective grey matter disruption was accompanied by a seemingly insufficient oligodendrocyte regenerative response, suggesting ongoing attempts at myelin repair, yet featured by a differentiation block. Importantly, the extent of myelin damage and OPC differentiation strongly correlated with proximity to tau pathology, linking cortical demyelination to neuronal and synaptic dysfunction within vulnerable AD regions. Together, our findings reveal cortical grey matter myelin disruption as a previously underrecognized, highly localized feature of AD pathology. By highlighting the tight intertwining of oligodendrocyte and myelin dynamics with tau-associated neurodegeneration, this work positions cortical myelin pathology as a potential new mechanistic and therapeutic avenue in AD.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Acta Neuropathologica
58 papers in training set
Top 0.1%
25.9%
2
Nature Communications
5641 papers in training set
Top 19%
9.5%
3
Acta Neuropathologica Communications
89 papers in training set
Top 0.2%
9.5%
4
Alzheimer's & Dementia
163 papers in training set
Top 0.8%
6.6%
50% of probability mass above
5
Brain
168 papers in training set
Top 0.7%
4.7%
6
Cell Reports
1498 papers in training set
Top 13%
3.1%
7
Alzheimer's & Dementia
14 papers in training set
Top 0.1%
3.1%
8
Communications Biology
993 papers in training set
Top 6%
3.1%
9
Journal of Neuroinflammation
61 papers in training set
Top 0.6%
2.4%
10
Molecular Neurodegeneration
55 papers in training set
Top 0.8%
2.3%
11
Neurobiology of Disease
148 papers in training set
Top 2%
2.3%
12
Molecular Psychiatry
282 papers in training set
Top 3%
2.1%
13
Translational Neurodegeneration
10 papers in training set
Top 0.2%
1.6%
14
eLife
5828 papers in training set
Top 53%
1.5%
15
Alzheimer's Research & Therapy
57 papers in training set
Top 1.0%
1.4%
16
Advanced Science
286 papers in training set
Top 7%
1.1%
17
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 36%
1.1%
18
The Journal of Neuroscience
1025 papers in training set
Top 9%
1.1%
19
Brain Communications
166 papers in training set
Top 3%
1.1%
20
Neuron
337 papers in training set
Top 5%
1.0%
21
Nature Neuroscience
252 papers in training set
Top 5%
0.9%
22
Scientific Reports
3612 papers in training set
Top 76%
0.8%
23
Science Advances
1243 papers in training set
Top 31%
0.8%
24
Nature Aging
60 papers in training set
Top 2%
0.6%
25
PLOS Biology
486 papers in training set
Top 15%
0.6%